Articles tagged with Binding Partners
Researchers have discovered how Fusobacterium nucleatum binds to human cell receptors CEACAM1 and CEACAM5, which are frequently overexpressed on many types of cancer cells. This binding mechanism is crucial for developing novel antitumor therapies.
University of Toronto researchers have developed a new material that repels both water and grease as well as standard non-stick coatings, but contains much lower amounts of per- and polyfluoroalkyl substances (PFAS). The material uses nanoscale fletching technology to achieve its performance, making it a safer alternative for consumer ...
Scientists at St. Jude Children's Research Hospital discovered that TEAD proteins promote differentiation by switching partners with INSM1 as neural progenitor cells mature. This finding highlights the complexity of brain development and the importance of accounting for context in studying neurodevelopment processes.
Scientists at MIT have developed a screening method to study protein-protein interactions, which are crucial in understanding disease mechanisms. The researchers created a synthetic molecule that binds tightly to a protein implicated in cancer metastasis, providing a potential tool for disrupting disease-causing interactions.
Researchers have determined the structure of human leukotriene B4 receptor 1 (hBLT1), a protein involved in inflammation and disease. The analysis reveals how the receptor recognizes its binding partners and interacts with them, opening up avenues for designing better drugs.
Biomedical engineers at the University of Toronto have identified an up-and-coming technique called affinity-controlled release, which allows proteins to stay at treatment sites for longer periods. This technology has potential applications in treating a range of medical conditions, including diabetes and stroke.
A team of scientists has found that water molecules form a 'funnel' around proteins, guiding them to potential binding partners. This collective water movement assists binding and supports the mutual recognition of biomolecules, allowing them to select or reject certain partners.
Researchers have discovered that proteins and ligands engage in a complex dance-like interaction, influencing the binding modes of ligands and receptor dynamics. This finding has implications for designing future diabetes treatments.